1. Introduction {#sec1}
===============

Methicillin resistant *S. aureus*(MRSA) remains as an important cause of infectious diseases acquired in hospitals and communities worldwide \[[@B1]--[@B3]\]. This pathogen is a common cause of cutaneous and soft tissue infections, as well as invasive illness, such as bacteremia, septic arthritis, osteomyelitis and necrotizing pneumonia \[[@B4], [@B5]\]. The therapy of these infections is often complicated once many MRSA strains carry multiple genes of antibiotic resistance \[[@B6], [@B7]\].

The high prevalence of infectious diseases caused by MRSA and other multidrug resistant bacteria has motivated the search for new antimicrobial agents and/or new compounds able to potentiate the antimicrobial activity of old antibiotics \[[@B8]--[@B10]\]. Several studies have evidenced that secondary metabolites derived from plant metabolism may be active against multi-drug resistant bacteria, including MRSA \[[@B11], [@B12]\].

The family Verbenaceae is made up of 75 genera with about 3000 species and the genus *Lippia* has about 200 species distributed in countries of Central and South America, as well as countries of tropical Africa \[[@B13]\]. *Lippia origanoides*H.B.K. ([Figure 1](#fig1){ref-type="fig"}) is a medicinal plant known in the Piauí state as *alecrim-do-campo*. Its leaves have been used as culinary seasoning and in traditional medicine as remedy for gastrointestinal disorders and as a general antiseptic for mouth, throat, and wounds \[[@B14], [@B15]\]. The essential oil is the most studied product obtained from *L. origanoides*H.B.K., which exhibits antigenotoxic effect in bacterial cells, antioxidant activity, low toxicity, as well as antimicrobial and antiparasite activities \[[@B16]--[@B21]\].

On the other hand, biological activities of extracts and partition fractions obtained from *L. origanoides*H.B.K need further studies, and as far as we know, the antibiotic-resistance modifying activity of its extracts has not been investigated yet. In the present study, the ethanol extract obtained from *L. origanoides*H.B.K., and different partition fractions and their majority compounds were tested for their antimicrobial activity alone or in combination with aminoglycoside antibiotics, aiming to evaluate its potential as a natural source of secondary metabolites acting as modulators of antibiotic resistance.

2. Materials and Methods {#sec2}
========================

2.1. Strains and Drugs {#sec2.1}
----------------------

All tests were performed with multidrug resistant bacterial strain of *Staphylococcus aureus*SA10 isolated from rectal swab (resistant to cephalothin, cephalexin, cefadroxil, penicillin G, ampicillin, amoxicillin, oxacillin, erythromycin, clarithromycin, azithromycin, clindamycin, moxifloxacin, ciprofloxacin, levofloxacin, nalidixic acid, tetracycline, neomycin, gentamicin and amikacin), which was kindly provided by Laboratory of Clinical Microbiology of the Universidade Federal da Paraiba. The standard strain *Staphylococcus aureus*ATCC25923 was used as positive controls. The strains were maintained on Nutrient Agar (Himedia, India) slant at 4°C, and prior to assay the cells were grown overnight at 37°C in Brain Heart Infusion (BHI, Himedia, India). Neomycin, amikacin, naringenin, carvacrol, thymol, and chlorpromazine were obtained from Sigma Chemical Corp., St. Louis, MO, USA. Antibiotics and chlorpromazine were dissolved in sterile water. Naringenin, carvacrol, and thymol were dissolved in dimethylsulfoxide (DMSO-MERCK) and the stock solutions were diluted with sterile water.

2.2. Plant Material {#sec2.2}
-------------------

Leaves of *Lippia origanoides*H.B.K. were collected in the county of José de Freitas (latitude 04°45′23′′ south and longitude 42°34′32′′ west), Piauí, Brazil. The plant material was identified and a voucher specimen was deposited with the number TEPB09205 at the Herbarium ''Graziela Barroso" of Universidade Federal do Piauí (UFPI).

2.3. Preparation of Extracts and Fractions {#sec2.3}
------------------------------------------

The leaves were dried at room temperature and powdered. The powdered material (1,120 g) was extracted by maceration using ethanol as solvent in the ratio of 1 : 3 (m/v) and the homogenate was allowed to stand for 72 h at room temperature. This procedure was realized in triplicate. The supernatants were then filtered, gathered, and concentrated under vacuum in a rotary evaporator (model Q-344B-Quimis, Brazil) and ultra thermal bath (model Q-214M2-Quimis, Brazil), yielding 309.5 g of ethanol extract (LOEE). A part of this extract was suspended in ethanol/water (1 : 1, v/v) and partitioned in solvents with increasing polarity (hexane, dichloromethane, and ethyl acetate), obtaining fractions hexane (LOHEX), dichloromethane (LODCM), and ethyl acetate (LOEA), respectively. The fractions were concentrated under vacuum in a rotary evaporator and lyophilized. After extraction with ethanol, the residue was macerated with ethanol/water (1 : 1, v/v) in the ratio of 1 : 3 (m/v), and the homogenate was allowed to stand for 72 h at room temperature. This procedure was repeated for three consecutive times. The supernatants were then filtered, gathered and concentrated under vacuum in a rotary evaporator and lyophilized, thereby obtaining the hydro alcoholic extract (LOHA).

2.4. Gas Chromatography/Mass Spectrometry (GC-MS) {#sec2.4}
-------------------------------------------------

The fractions\' constituents were converted to silylated derivatives according to Isidorov et al. \[[@B22]\], with modifications. Two milligrams of each fraction were mixed with 100 *μ*L of bis(trimethylsilyl)trifluoroacetamide and trimethylsilyl chloride 1%. The mix was maintained at 85°C under agitation for 1 hour. The silylated fractions were analyzed after injection of 1 µL in a gas chromatograph (Shimadzu GC-17A) with a flame ionization detector (FID) model ISQ and coupled to an mass spectrometer model GCMS-QP5050A equipped with a DB-5 HT (Agilent, Palo Alto, CA, USA) 95% methyl-polysiloxane and 5% phenyl capillary column (intern diameter = 0.25 mm, length 30 m, film thickness = 0,1 µm). Operating conditions were as follows: injector temperature, 260°C; detector temperature, 300°C; carrier gas (Helium), flow rate of 1 mL min^−1^. Oven temperature was initially 60°C (0,5 min) and was then raised to 260°C (5 min) at a rate of 6°C min^−1^; then it was heated to 300°C (10 min) at a rate of 12°C min^−1^. The mass spectrometry conditions were as follows: scan mode with acquisition time of 52.21 min; ionization voltage, 70 eV; mass range, 40--650 Da; ion source temperature, 200°C. Compounds were preliminarily identified by characteristic fragmentation and by comparison of NIST 2.0 mass spectra libraries.

2.5. Evaluation of the Antibacterial Activity {#sec2.5}
---------------------------------------------

Stock solutions of LOHEX, LODCM, and LOEA were prepared by dissolving 10 mg of each product in 1 mL of dimethyl sulfide, thus starting with an initial concentration of 10 mg/mL. The resulting solution was then diluted to 1024 *μ*g/mL in sterile water. Minimal inhibitory concentrations (MICs) of the LOHEX, LODCM, LOEA, carvacrol, thymol, naringenin, and chlorpromazine were determined by the microdilution assay in BHI broth 10% with bacterial suspensions of 10^5^ CFU/mL. The final concentrations of the fractions and compounds ranged from 512 to 8 *μ*g/mL \[[@B23]\]. MICs of neomycin and amikacin were determined for the same method with antibiotic concentrations ranging from 2,500 to 2.4 *μ*g/mL.

2.6. Modulation of the Antibiotic Activity {#sec2.6}
------------------------------------------

For evaluation of extracts and their majority compounds as antibiotic resistance modulators, MICs of the antibiotics were determined in the presence or absence of subinhibitory concentrations (1/8 MIC) of the extracts (128 *μ*g/mL), naringenin (128 *μ*g/mL), carvacrol and thymol (32 *μ*g/mL), and chlorpromazine (8 *μ*g/mL) \[[@B24]\]. The plates were incubated at 37°C for 24 h.

2.7. Statistical Analysis {#sec2.7}
-------------------------

Each experiment was performed six times and the results were normalized by calculation of geometric mean values. Error deviation and standard deviation of the geometric mean were revealed. Statistical analyses were performed using GraphPad Prism, version 5.02. Differences between treatment with antibiotics in the absence and the presence of the *L. origanoides*extract and fractions, as well as carvacrol, thymol, naringenin, and chlorpromazine were examined using two-way analysis of variance (ANOVA). The differences mentioned above were analyzed by Bonferroni posttest and they were considered statistically significant when *P* \< 0.05.

3. Results and Discussion {#sec3}
=========================

3.1. Evaluation of the Antibacterial Activity {#sec3.1}
---------------------------------------------

The antibacterial activity of the natural products from *L. origanoides*H.B.K., as well as the majority compounds of the LOHEX (carvacrol and thymol) and LODCM (naringenin) was tested by microdilution method against *S. aureus*strains (ATCC 25923 and SA10). Plant extracts are considered as having a good inhibitory activity if they present MICs ≤ 100 *μ*g/mL, a moderate inhibitory activity if they present MICs ranging from 100 to 500 *μ*g/mL, a weak inhibitory activity if they present MICs ranging from 500 to 1000 *μ*g/mL, and no inhibitory activity if they present MICs \> 1000 *μ*g/mL \[[@B25], [@B26]\]. According to these criteria, the extract and fractions, as well as, naringenin did not show antibacterial activity against the *S. aureus* strains (once they showed MICs ≥ 1024 *μ*g/mL). On the other hand, carvacrol and thymol presented a moderate inhibitory activity (MIC 256 *μ*g/mL) against the *S. aureus* strains.

3.2. Modulation of Antibiotic Activity {#sec3.2}
--------------------------------------

When LOEE or the fractions LOHEX and LODCM were added to the growth medium at subinhibitory concentration, a reduction in the MIC of at least 10-fold for neomycin and at least 5-fold for amikacin was verified (Figures [2](#fig2){ref-type="fig"}--[4](#fig4){ref-type="fig"}). To the best of our knowledge, this is the first time that *Lippia origanoides* H.B.K. extracts are described as enhancers of the aminoglycosides activity against MRSA, and the results were compatible with those found for other medicinal plants \[[@B10], [@B27]--[@B29]\].

After crossing the cell wall and the cell membrane, aminoglycosides bind to the ribosomal subunit 30S, interfering with the binding of mRNA, leading to the synthesis of anomalous proteins, which are inserted into plasma membrane changing its permeability \[[@B30]\]. Resistance to aminoglycosides in *S. aureus* is frequently related to enzymatic inactivation \[[@B31]\], but it can be mediated by membrane transporter proteins able to pump the antibiotic to the extracellular medium, as LmrS efflux protein \[[@B32], [@B33]\].

Decrease in the MICs of antibiotics tested was also verified when LOEE, LOHEX, and LODCM were replaced by chlorpromazine at subinhibitory concentration. The role of chlorpromazine as inhibitor of bacterial efflux systems has already been well studied \[[@B34], [@B35]\]. This result indicates a possible mechanism mediated by efflux pump for resistance to neomycin and amikacin in the SA10 strain, which could be inhibited by phytochemicals present in LOEE and in both LOHEX and LODCM fractions, although further studies are needed to confirm such mechanism.

3.3. Phytochemical Prospection {#sec3.3}
------------------------------

Through phytochemical prospecting of the fractions studied, several classes of secondary metabolites were identified. The majority compounds found in the LOHEX were the monoterpenoids carvacrol and thymol, besides other minority components ([Table 1](#tab1){ref-type="table"} and [Figure 6](#fig6){ref-type="fig"}). The antimicrobial activity of phenolic compounds such as carvacrol and thymol has been demonstrated previously \[[@B36]\], including against MRSA \[[@B37]\]. Due to their lipophilicity, these compounds can intercalate in the phospholipid bilayer, increasing the permeability of the cell membrane, dissipation of the proton-motive force, and leakage of inorganic ions, resulting in lysis and cell death \[[@B38], [@B39]\].

Flavonoids aglycones were the main phytochemicals found in the fraction LODCM ([Table 2](#tab2){ref-type="table"} and [Figure 6](#fig6){ref-type="fig"}), including the flavanones naringenin (in the keto and enol forms), eriodictyol and hesperetin, the isoflavones dihydroglycitein and 3′hydroxy-irilone, and the flavan-3-ol (+)catechin. Some lipophilic flavonoids can react with bacterial membrane \[[@B40]\], besides forming complexes with proteins \[[@B41]\]. As already mentioned, these mechanisms may increase the membrane permeability and inhibit efflux systems dependent of proton-motive force, leading to a bigger accumulate of antibiotics into the bacterial cell \[[@B34]\]. In fact, the modulatory effect of flavonoids on resistance to quinolones and tetracycline has already been verified in *Staphylococcus aureus* \[[@B42]--[@B44]\].

With regard to the modulatory effect found in this study, it could be attributed to an interaction of LOHEX and LODCM components in the plasma membrane, leading to an increase in the cell permeability to the aminoglycosides. Furthermore, this interaction could inhibit efflux systems dependent of proton-motive force, as LmrS protein, contributing to the increase in the intracellular levels of antibiotics and leading to an enhancement of the aminoglycoside activity against MRSA.

Thymol and carvacrol did not modulate the antistaphylococcal activity of the neomycin or amikacin in the SA10 strain ([Figure 3](#fig3){ref-type="fig"}), and the modulatory activity verified for naringenin was lower than that showed by LODCM ([Figure 4](#fig4){ref-type="fig"}). These results suggest that the modulatory activity verified for LOHEX and LODCM is not only caused by their majority compounds, but it could be due to a synergism among their components. However, further investigations with different phytochemicals alone and in different combinations between them are needed to test this hypothesis.

LOEA also did not modulate the activity of the aminoglycosides tested ([Figure 5](#fig5){ref-type="fig"}). In this fraction was found a high content of irilone *O-*heterosides, besides the aglycone catechin ([Table 3](#tab3){ref-type="table"} and [Figure 6](#fig6){ref-type="fig"}). It has been demonstrated that addition of hydrophilic groups as glycosides becomes the compound less effective at inhibiting Gram-positive bacteria \[[@B45], [@B46]\]. It was suggested that the lack of affinity for the phospholipid bilayer or specific receptors on the cell membrane is the motive for this decrease in the antibacterial activity \[[@B47]\]. The lack of modulatory effect in the activity of the aminoglycosides tested showed by LOEA also may be related to the bigger hydrophilicity of the compounds present in this fraction.

4. Conclusions {#sec4}
==============

In the present work, it was verified that LOEE and the nonpolar fractions LOHEX and LODCM were able to potentiate the activity of neomycin and amikacin against a MRSA strain in vitro, which may be related to the low polarity of its phytochemicals. Aminoglycosides have been used in the initial empiric treatment of endocarditis caused by Gram-positive bacteria, including *S. aureus*, but the high frequency of resistant strains and adverse reactions have discouraged its clinical use \[[@B48]\]. The results obtained indicated that *Lippia origanoides*H.B.K. could be a source of secondary metabolites for use in association with neomycin and amikacin in the antibiotic chemotherapy of infections caused by MRSA.
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###### 

Chemical composition of *Lippia origanoides*H.B.K. hexane fraction (LOHEX).

  Peaks   Compound              RT^a^    Area (%)
  ------- --------------------- -------- ----------
  1       Ethylene glycol       3.600    0.45
  2       *p*-Cymene            4.054    2.44
  3       1.8-Cineol            4.161    3.74
  4       Terpinen-4-ol         6.676    0.51
  5       *α*-Terpineol         6.944    0.87
  6       Thymol methyl ether   7.799    1.32
  7       Thymol                9.514    38.67
  8       *α*-Terpineol         9.636    0.33
  9       Carvacrol             9.855    36.17
  10      Not identified        10.358   0.42
  11      *α*-Copaene           10.600   0.61
  12      *β*-Caryophyllene     11.439   2.01
  13      Theophylline          13.176   2.72
  14      *β*-Bisabolene        13.244   0.50
  15      Not identified        13.458   4.79
  16      Caryophyllene oxide   14.553   0.95
  17      Not identified        15.623   0.38
  18      Not identified        15.684   0.37
  19      Palmitic acid         22.518   2.44
  20      Menthol               24.449   0.31

^a^Retention time.

###### 

Chemical composition of *Lippia origanoides*H.B.K. dichloromethane fraction (LODCM).

  Peaks   Compound                       RT^a^    Area (%)
  ------- ------------------------------ -------- ----------
  1       Thymol                         9.524    1.26
  2       Carvacrol                      9.864    1.77
  3       2,3-Dimethylcyclopentenol      12.983   1.41
  4       Theophylline                   13.239   0.48
  5       Cycloleucine                   13.357   0.34
  6       Not identified                 13.547   4.98
  7       7-Methylxanthine               14.700   0.64
  8       Not identified                 15.713   1.37
  9       3′-Hydroxy-irilone             27.474   0.48
  10      Dihydroglycitein               32.615   4.77
  11      Not identified                 33.277   4.49
  12      Not identified                 33.550   29.49
  13      Naringenin (enol form)         33.593   15.56
  14      Naringenin (keto form)         33.637   10.4
  15      Not identified                 33.754   6.3
  16      Eriodictyol                    33.830   4.49
  17      Hesperetin                     33.976   0.54
  18      Not identified                 34.755   7.82
  19      (+)Catechin                    34.899   2.62
  20      2,4,6-Trihydroxybenzoic acid   36.439   0.79

^a^Retention time.

###### 

Chemical composition of *Lippia origanoides*H.B.K. ethyl acetate fraction (LODCM).

  Peaks   Compound                                 RT^a^    Area (%)
  ------- ---------------------------------------- -------- ----------
  1       Ethylene glycol                          3.625    0.97
  2       Glycerol                                 9.080    8.19
  3       Not identified                           16.937   2.22
  4       Protocatechuic acid                      19.191   9.68
  5       L-Rhamnose                               19.366   5.63
  6       2-Keto-D-gluconic                        19.492   1.15
  7       D-Xylopyranose                           20.740   2.12
  8       Gallic acid                              21.575   1.46
  9       D-Mannose                                22.312   1.27
  10      Not identified                           27.956   0.92
  11      Not identified                           29.948   1.06
  12      Isomaltulose                             31.022   16.37
  13      Isomaltulose                             31.377   1.29
  14      D-Turanose                               34.476   1.62
  15      Catechin                                 34.838   11.61
  16      3′-Hydroxy-5-furanoside-dihydroirilone   44.546   4.54
  17      3′-Hydroxy-5-inosose-irilone             44.980   2.32
  18      3′-Hydroxy-5-piranoside-dihidroirilone   46.179   3.07
  19      3′-Hydroxy-5-inosose-dihydroirilone      47.991   5.08

^a^Retention time.
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